Patrick J Lao1,2, Ben L Handen3,4,5,6, Tobey J Betthauser1,2, Iulia Mihaila2,7, Sigan L Hartley2,7, Annie D Cohen3, Dana L Tudorascu3,8,9, Peter D Bulova8, Brian J Lopresti10, Rameshwari V Tumuluru3, Dhanabalan Murali1,2, Chester A Mathis10, Todd E Barnhart1, Charles K Stone11, Julie C Price10,12, Darlynne A Devenny13, Sterling C Johnson14, William E Klunk3,15, Bradley T Christian1,2,16. 1. Department of Medical Physics, University of Wisconsin-Madison, Madison, WI, USA. 2. University of Wisconsin-Madison, Waisman Center, Madison, WI, USA. 3. Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA. 4. Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA. 5. Department of Psychology, University of Pittsburgh, Pittsburgh, PA, USA. 6. Department of Instruction and Learning, University of Pittsburgh, Pittsburgh, PA, USA. 7. Department of Human Development and Family Studies, University of Wisconsin-Madison, Madison, WI, USA. 8. Department of Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA. 9. Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA. 10. Department of Radiology, University of Pittsburgh, Pittsburgh, PA, USA. 11. Department of Cardiovascular Medicine, University of Wisconsin-Madison, Madison, WI, USA. 12. Department of Radiology, Massachusetts General Hospital, Charlestown, MA, USA. 13. New York State Institute for Research in Developmental Disabilities, Staten Island, NY, USA. 14. Department of Medicine-Geriatrics, University of Wisconsin-Madison, Madison, WI, USA. 15. Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA. 16. Department of Psychiatry, University of Wisconsin-Madison, Madison, WI, USA.
Abstract
BACKGROUND: The Down syndrome (DS) population is genetically predisposed to amyloid-β protein precursor overproduction and Alzheimer's disease (AD). OBJECTIVE: The temporal ordering and spatial association between amyloid-β, glucose metabolism, and gray matter (GM) volume in the DS population can provide insight into those associations in the more common sporadic AD. METHODS: Twenty-four adults (13 male, 11 female; 39±7 years) with DS underwent [11C]PiB, [18F]FDG, and volumetric MRI scans. Voxel-wise associations between PiB SUVR, FDG SUVR, and GM volume were investigated, with and without individual adjustments for variables of interest. RESULTS: Positive associations of PiB and age were widespread throughout the neocortex and striatum. Negative associations of FDG and age (frontal, parietal, and temporal cortex) and of GM volume and age (frontal and insular cortex) were observed. PiB and FDG were negatively associated in parietal cortex, after adjustment for GM volume. CONCLUSIONS: In adults with DS, early amyloid-β accumulation in the striatum is divergent from sporadic AD; however, despite the early striatal amyloid-β, glucose hypometabolism was confined to the typical AD-associated regions, which occurs similarly in autosomal dominant AD. Importantly, the glucose hypometabolism was not explained solely by increased partial volume effect due to GM volume reductions.
BACKGROUND: The Down syndrome (DS) population is genetically predisposed to amyloid-β protein precursor overproduction and Alzheimer's disease (AD). OBJECTIVE: The temporal ordering and spatial association between amyloid-β, glucose metabolism, and gray matter (GM) volume in the DS population can provide insight into those associations in the more common sporadic AD. METHODS: Twenty-four adults (13 male, 11 female; 39±7 years) with DS underwent [11C]PiB, [18F]FDG, and volumetric MRI scans. Voxel-wise associations between PiB SUVR, FDG SUVR, and GM volume were investigated, with and without individual adjustments for variables of interest. RESULTS: Positive associations of PiB and age were widespread throughout the neocortex and striatum. Negative associations of FDG and age (frontal, parietal, and temporal cortex) and of GM volume and age (frontal and insular cortex) were observed. PiB and FDG were negatively associated in parietal cortex, after adjustment for GM volume. CONCLUSIONS: In adults with DS, early amyloid-β accumulation in the striatum is divergent from sporadic AD; however, despite the early striatal amyloid-β, glucose hypometabolism was confined to the typical AD-associated regions, which occurs similarly in autosomal dominant AD. Importantly, the glucose hypometabolism was not explained solely by increased partial volume effect due to GM volume reductions.
Entities:
Keywords:
Alzheimer’s disease; Down syndrome; Pittsburgh compound B; amyloid-β; fluorodeoxyglucose; glucose metabolism; gray matter; magnetic resonance imaging
Authors: Brian J Lopresti; William E Klunk; Chester A Mathis; Jessica A Hoge; Scott K Ziolko; Xueling Lu; Carolyn C Meltzer; Kurt Schimmel; Nicholas D Tsopelas; Steven T DeKosky; Julie C Price Journal: J Nucl Med Date: 2005-12 Impact factor: 10.057
Authors: B Rumble; R Retallack; C Hilbich; G Simms; G Multhaup; R Martins; A Hockey; P Montgomery; K Beyreuther; C L Masters Journal: N Engl J Med Date: 1989-06-01 Impact factor: 91.245
Authors: Vincent Doré; Victor L Villemagne; Pierrick Bourgeat; Jurgen Fripp; Oscar Acosta; Gael Chetélat; Luping Zhou; Ralph Martins; Kathryn A Ellis; Colin L Masters; David Ames; Oliver Salvado; Christopher C Rowe Journal: JAMA Neurol Date: 2013-07 Impact factor: 18.302
Authors: Victor L Villemagne; Samantha Burnham; Pierrick Bourgeat; Belinda Brown; Kathryn A Ellis; Olivier Salvado; Cassandra Szoeke; S Lance Macaulay; Ralph Martins; Paul Maruff; David Ames; Christopher C Rowe; Colin L Masters Journal: Lancet Neurol Date: 2013-03-08 Impact factor: 44.182
Authors: Rebecca L McNamee; Seong-Hwan Yee; Julie C Price; William E Klunk; Bedda Rosario; Lisa Weissfeld; Scott Ziolko; Michael Berginc; Brian Lopresti; Steven Dekosky; Chester A Mathis Journal: J Nucl Med Date: 2009-02-17 Impact factor: 10.057
Authors: Yi Li; Juha O Rinne; Lisa Mosconi; Elizabeth Pirraglia; Henry Rusinek; Susan DeSanti; Nina Kemppainen; Kjell Någren; Byeong-Chae Kim; Wai Tsui; Mony J de Leon Journal: Eur J Nucl Med Mol Imaging Date: 2008-06-20 Impact factor: 9.236
Authors: Eric E Abrahamson; Elizabeth Head; Ira T Lott; Benjamin L Handen; Elliott J Mufson; Bradley T Christian; William E Klunk; Milos D Ikonomovic Journal: Dev Neurobiol Date: 2019-08-17 Impact factor: 3.964
Authors: Sylvia E Perez; Jennifer C Miguel; Bin He; Michael Malek-Ahmadi; Eric E Abrahamson; Milos D Ikonomovic; Ira Lott; Eric Doran; Melissa J Alldred; Stephen D Ginsberg; Elliott J Mufson Journal: Acta Neuropathol Date: 2019-02-07 Impact factor: 17.088
Authors: Michael S Rafii; Beau M Ances; Nicole Schupf; Sharon J Krinsky-McHale; Mark Mapstone; Wayne Silverman; Ira Lott; William Klunk; Elizabeth Head; Brad Christian; Florence Lai; H Diana Rosas; Shahid Zaman; Melissa E Petersen; Andre Strydom; Juan Fortea; Benjamin Handen; Sid O'Bryant Journal: Alzheimers Dement (Amst) Date: 2020-10-27
Authors: Joshua A Kulas; Whitney F Franklin; Nicholas A Smith; Gunjan D Manocha; Kendra L Puig; Kumi Nagamoto-Combs; Rachel D Hendrix; Giulio Taglialatela; Steven W Barger; Colin K Combs Journal: Am J Physiol Endocrinol Metab Date: 2018-11-13 Impact factor: 4.310
Authors: Mark Mapstone; Thomas J Gross; Fabio Macciardi; Amrita K Cheema; Melissa Petersen; Elizabeth Head; Benjamin L Handen; William E Klunk; Bradley T Christian; Wayne Silverman; Ira T Lott; Nicole Schupf Journal: Alzheimers Dement (Amst) Date: 2020-04-05
Authors: Heather M Snyder; Lisa J Bain; Adam M Brickman; Maria C Carrillo; Anna J Esbensen; Joaquin M Espinosa; Fabian Fernandez; Juan Fortea; Sigan L Hartley; Elizabeth Head; James Hendrix; Priya S Kishnani; Florence Lai; Patrick Lao; Cynthia Lemere; William Mobley; Elliott J Mufson; Huntington Potter; Shahid H Zaman; Ann-Charlotte Granholm; H Diana Rosas; Andre Strydom; Michelle Sie Whitten; Michael S Rafii Journal: Alzheimers Dement Date: 2020-06-16 Impact factor: 16.655